June 2023
166 articles-
Jun 29 · 22:07Biotechnology Daily
Scientists use long-approved GSK HIV drug to stave off dementia, Huntington's proteins in mice
-
Jun 29 · 22:05Biotechnology Daily
Dexcom sets new user records in first quarter following G7 kickoff
-
Jun 29 · 22:04Biotechnology Daily
'More in the hopper': European Big Pharmas hint M&A could ramp up
-
Jun 29 · 22:03Biotechnology Daily
Intuitive Surgical collects new prostate procedure clearances for its single-port robot
-
Jun 29 · 22:01Bio Business News
Astellas keeps the big buyouts rolling, inking $5.9B Iveric takeover ahead of FDA eye disease ruling
-
Jun 29 · 22:00Bio Business News
Patient Square Capital launches medtech backer Elevage with $300M investment
-
Jun 29 · 21:58Bio Business News
Sanofi bets $750M to enter glycogen-lined Maze deal with lead asset waiting in the middle
-
Jun 29 · 21:57Bio Business News
ResMed CEO on Philips' return to CPAP market: 'Game on'
-
Jun 29 · 21:21Market Watch
Goldman Sachs stock posting biggest one-day gain since November
-
Jun 29 · 00:40Biotechnology Daily
Still under partial hold, Sanofi makes case for safety of MS med from Principia buyout
-
Jun 29 · 00:39Biotechnology Daily
'Lots of ways for donanemab to win' in Alzheimer's, Lilly says. Now, it just needs the data
-
Jun 29 · 00:37Biotechnology Daily
Merck reveals HIV combo trial is back in the running after FDA partial hold lifted
-
Jun 29 · 00:35Biotechnology Daily
AbbVie closes cystic fibrosis chapter after combo 'just did not work'
-
Jun 29 · 00:25Bio Business News
Amgen cuts lupus programs for futility hours after Lilly officially walks away from one, too
-
Jun 29 · 00:24Bio Business News
Edwards Lifesciences pegs growing TAVR sales to hospital hiring gains
-
Jun 29 · 00:17Bio Business News
Gilead's R&D spending spiked 25% in Q1, shortening investment gap with peers
-
Jun 29 · 00:15Bio Business News
Joe Jimenez's Aditum finds fresh twist on old idea, paying $10M for autoimmune BTK inhibitor
-
Jun 28 · 22:53Market Watch
Motorcar Parts Shares Up 18% After Bison Reports Stock Purchase
-
Jun 28 · 02:40Biotechnology Daily
After gathering enough Nektar, Lilly hands back rights to immunology med post-lupus fail
-
Jun 28 · 02:39Biotechnology Daily
Boston Scientific still surging upward, with 12% sales bump amid product launches, M&A moves
-
Jun 28 · 02:37Biotechnology Daily
Spurned by Big Pharma collaborators, Sangamo lays off 27% of US staff in latest refocus
-
Jun 28 · 02:36Biotechnology Daily
Clinical trial matchmaker myTomorrows launches AI-backed recruiting tool
-
Jun 28 · 02:35Bio Business News
Sanofi, after $8B outlay, sees M&A strategy deliver 2 more duds
-
Jun 28 · 02:34Bio Business News
Antiva bags $53M in rare series E to finance quest for pivotal HPV treatment data